Drugs / MenABCWY vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04707391 | Jan 2021 → May 2023 | meningococcal meningitis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MenABCWY vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04707391 ↗ |
| Modality | Vaccine | “MenABCWY vaccine” NCT04707391 ↗ |
| Route | Intramuscular | “MenABCWY vaccine administered intramuscularly” NCT04707391 ↗ |